Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice. 2010

Michele Barone, and Sabina Tanzi, and Katia Lofano, and Maria Principia Scavo, and Maria Pricci, and Lucia Demarinis, and Samanta Papagni, and Raffaella Guido, and Eugenio Maiorano, and Giuseppe Ingravallo, and Maria Cristina Comelli, and Antonio Francavilla, and Alfredo Di Leo
Department of Emergency and Organ Transplantation, University of Bari, Ospedale Policlinico, Bari, Italy.

Most sporadic colorectal cancers (CRCs) develop through the adenoma-carcinoma sequence pathway and are initiated by adenomatous polyposis coli (APC) gene mutations. Estrogen receptor beta (ERbeta) is recognized to progressively reduce its expression in adenomatous and carcinomatous tissues in humans. Moreover, ERbeta deficiency enhances small intestinal tumorigenesis in rodents. In the Apc(Min/+) mouse model, we evaluated intestinal polyp development and ERbeta expression plus other biological parameters influencing tumor growth (epithelial cell proliferation, apoptosis and migration) following the addition of a combination of the ERbeta-selective agonist silymarin (SIL) and/or lignin (LIG) to a high-fat/low-fiber diet. Forty-five Apc(Min/+) mice were divided in four groups: animals fed on the tumorigenic high-fat/low-fiber diet, the tumorigenic diet supplemented with SIL (0.02%) or purified LIG (6.24%) or SIL (0.005%) + LIG (6.24%). In these animals, we assessed polyp number and volume and their degree of dysplasia together with ERbeta messenger RNA (mRNA) and protein levels and epithelial cell proliferation, migration and apoptosis. The latter group of parameters was evaluated in normal and adenomatous mucosa and the results compared with those found in wild-type (WT) mice fed on the control diet. The addition of SIL or LIG to the diet and even more the specific combination of the two significantly counteracted intestinal tumorigenesis and increased ERbeta mRNA and protein levels. Cell proliferation and apoptosis were rebalanced and cell migration accelerated, restoring values similar to those observed in WT animals. Our results further support a protective effect of ERbeta in CRC suggesting the use of the combination of SIL-LIG as a potential approach against CRC development.

UI MeSH Term Description Entries
D007124 Immunoenzyme Techniques Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens. Antibody Enzyme Technique, Unlabeled,Enzyme Immunoassay,Enzyme-Labeled Antibody Technique,Immunoassay, Enzyme,Immunoperoxidase Techniques,Peroxidase-Antiperoxidase Complex Technique,Peroxidase-Labeled Antibody Technique,Antibody Enzyme Technic, Unlabeled,Enzyme-Labeled Antibody Technic,Immunoenzyme Technics,Immunoperoxidase Technics,Peroxidase-Antiperoxidase Complex Technic,Peroxidase-Labeled Antibody Technic,Antibody Technic, Enzyme-Labeled,Antibody Technic, Peroxidase-Labeled,Antibody Technics, Enzyme-Labeled,Antibody Technics, Peroxidase-Labeled,Antibody Technique, Enzyme-Labeled,Antibody Technique, Peroxidase-Labeled,Antibody Techniques, Enzyme-Labeled,Antibody Techniques, Peroxidase-Labeled,Enzyme Immunoassays,Enzyme Labeled Antibody Technic,Enzyme Labeled Antibody Technique,Enzyme-Labeled Antibody Technics,Enzyme-Labeled Antibody Techniques,Immunoassays, Enzyme,Immunoenzyme Technic,Immunoenzyme Technique,Immunoperoxidase Technic,Immunoperoxidase Technique,Peroxidase Antiperoxidase Complex Technic,Peroxidase Antiperoxidase Complex Technique,Peroxidase Labeled Antibody Technic,Peroxidase Labeled Antibody Technique,Peroxidase-Antiperoxidase Complex Technics,Peroxidase-Antiperoxidase Complex Techniques,Peroxidase-Labeled Antibody Technics,Peroxidase-Labeled Antibody Techniques,Technic, Enzyme-Labeled Antibody,Technic, Immunoenzyme,Technic, Immunoperoxidase,Technic, Peroxidase-Antiperoxidase Complex,Technic, Peroxidase-Labeled Antibody,Technics, Enzyme-Labeled Antibody,Technics, Immunoenzyme,Technics, Immunoperoxidase,Technics, Peroxidase-Antiperoxidase Complex,Technics, Peroxidase-Labeled Antibody,Technique, Enzyme-Labeled Antibody,Technique, Immunoenzyme,Technique, Immunoperoxidase,Technique, Peroxidase-Antiperoxidase Complex,Technique, Peroxidase-Labeled Antibody,Techniques, Enzyme-Labeled Antibody,Techniques, Immunoenzyme,Techniques, Immunoperoxidase,Techniques, Peroxidase-Antiperoxidase Complex,Techniques, Peroxidase-Labeled Antibody
D007414 Intestinal Neoplasms Tumors or cancer of the INTESTINES. Cancer of Intestines,Intestinal Cancer,Cancer of the Intestines,Intestines Cancer,Intestines Neoplasms,Neoplasms, Intestinal,Cancer, Intestinal,Cancer, Intestines,Cancers, Intestinal,Cancers, Intestines,Intestinal Cancers,Intestinal Neoplasm,Intestines Cancers,Intestines Neoplasm,Neoplasm, Intestinal,Neoplasm, Intestines,Neoplasms, Intestines
D007417 Intestinal Polyps Discrete abnormal tissue masses that protrude into the lumen of the INTESTINE. A polyp is attached to the intestinal wall either by a stalk, pedunculus, or by a broad base. Intestinal Polyp,Polyp, Intestinal,Polyps, Intestinal
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000236 Adenoma A benign epithelial tumor with a glandular organization. Adenoma, Basal Cell,Adenoma, Follicular,Adenoma, Microcystic,Adenoma, Monomorphic,Adenoma, Papillary,Adenoma, Trabecular,Adenomas,Adenomas, Basal Cell,Adenomas, Follicular,Adenomas, Microcystic,Adenomas, Monomorphic,Adenomas, Papillary,Adenomas, Trabecular,Basal Cell Adenoma,Basal Cell Adenomas,Follicular Adenoma,Follicular Adenomas,Microcystic Adenoma,Microcystic Adenomas,Monomorphic Adenoma,Monomorphic Adenomas,Papillary Adenoma,Papillary Adenomas,Trabecular Adenoma,Trabecular Adenomas
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

Michele Barone, and Sabina Tanzi, and Katia Lofano, and Maria Principia Scavo, and Maria Pricci, and Lucia Demarinis, and Samanta Papagni, and Raffaella Guido, and Eugenio Maiorano, and Giuseppe Ingravallo, and Maria Cristina Comelli, and Antonio Francavilla, and Alfredo Di Leo
December 2004, Cancer research,
Michele Barone, and Sabina Tanzi, and Katia Lofano, and Maria Principia Scavo, and Maria Pricci, and Lucia Demarinis, and Samanta Papagni, and Raffaella Guido, and Eugenio Maiorano, and Giuseppe Ingravallo, and Maria Cristina Comelli, and Antonio Francavilla, and Alfredo Di Leo
March 2006, International journal of radiation biology,
Michele Barone, and Sabina Tanzi, and Katia Lofano, and Maria Principia Scavo, and Maria Pricci, and Lucia Demarinis, and Samanta Papagni, and Raffaella Guido, and Eugenio Maiorano, and Giuseppe Ingravallo, and Maria Cristina Comelli, and Antonio Francavilla, and Alfredo Di Leo
October 2002, American journal of physiology. Endocrinology and metabolism,
Michele Barone, and Sabina Tanzi, and Katia Lofano, and Maria Principia Scavo, and Maria Pricci, and Lucia Demarinis, and Samanta Papagni, and Raffaella Guido, and Eugenio Maiorano, and Giuseppe Ingravallo, and Maria Cristina Comelli, and Antonio Francavilla, and Alfredo Di Leo
October 2003, Medicine and science in sports and exercise,
Michele Barone, and Sabina Tanzi, and Katia Lofano, and Maria Principia Scavo, and Maria Pricci, and Lucia Demarinis, and Samanta Papagni, and Raffaella Guido, and Eugenio Maiorano, and Giuseppe Ingravallo, and Maria Cristina Comelli, and Antonio Francavilla, and Alfredo Di Leo
November 2017, Oncotarget,
Michele Barone, and Sabina Tanzi, and Katia Lofano, and Maria Principia Scavo, and Maria Pricci, and Lucia Demarinis, and Samanta Papagni, and Raffaella Guido, and Eugenio Maiorano, and Giuseppe Ingravallo, and Maria Cristina Comelli, and Antonio Francavilla, and Alfredo Di Leo
October 2006, Mammalian genome : official journal of the International Mammalian Genome Society,
Michele Barone, and Sabina Tanzi, and Katia Lofano, and Maria Principia Scavo, and Maria Pricci, and Lucia Demarinis, and Samanta Papagni, and Raffaella Guido, and Eugenio Maiorano, and Giuseppe Ingravallo, and Maria Cristina Comelli, and Antonio Francavilla, and Alfredo Di Leo
September 1998, Carcinogenesis,
Michele Barone, and Sabina Tanzi, and Katia Lofano, and Maria Principia Scavo, and Maria Pricci, and Lucia Demarinis, and Samanta Papagni, and Raffaella Guido, and Eugenio Maiorano, and Giuseppe Ingravallo, and Maria Cristina Comelli, and Antonio Francavilla, and Alfredo Di Leo
January 2010, Neoplasia (New York, N.Y.),
Michele Barone, and Sabina Tanzi, and Katia Lofano, and Maria Principia Scavo, and Maria Pricci, and Lucia Demarinis, and Samanta Papagni, and Raffaella Guido, and Eugenio Maiorano, and Giuseppe Ingravallo, and Maria Cristina Comelli, and Antonio Francavilla, and Alfredo Di Leo
January 2003, Nutrition and cancer,
Michele Barone, and Sabina Tanzi, and Katia Lofano, and Maria Principia Scavo, and Maria Pricci, and Lucia Demarinis, and Samanta Papagni, and Raffaella Guido, and Eugenio Maiorano, and Giuseppe Ingravallo, and Maria Cristina Comelli, and Antonio Francavilla, and Alfredo Di Leo
August 1998, Cancer letters,
Copied contents to your clipboard!